Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial

Clinical trial NCT06965231 · RECRUITING

Trial details

NCT number: NCT06965231
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma of Skin Acral Melanoma Stage II Melanoma

Start date: 2025-01-01
Primary completion: 2028-12-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.